Literature DB >> 7426181

Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.

J Camm, D Ward, R Spurrell.   

Abstract

Ten patients who suffered spontaneous paroxysms of atrial flutter were investigated by electrophysiological techniques. Two had overt Wolff-Parkinson-White syndrome; three Lown-Ganong-Levine syndrome; and one a concealed accessory atrioventricular connection. Atrial flutter was initiated, at study, by right atrial pacing and electrograms from the right atrium and coronary sinus were observed for at least five minutes to ensure stable flutter in both atria. Atrial flutter was terminated by 2.5 s or 5 s bursts of atrial pacing at rates 10, 50, or 100 beats/min faster than the intrinsic flutter rate in only two patients. Atrial flutter, which was reinitiated in two patients, was then treated with intravenous disopyramide phosphate, 2 mg/kg body weight, infused over five minutes. In all 10 patients the atrial rate slowed from a mean of 310 +/- 39 beats/min to 217 +/- 27 beats/min and atrial flutter terminated in one case. Though the mean ventricular rate fell from 161 +/- 52 beats/min to 156 +/- 45 beats/min the atrioventricular conduction ratio fell from 2.17 +/- 0.86 to 1.55 +/- 0.59 and four patients were left with symptomatically significant increases of ventricular rate. In seven of nine patients overdrive atrial pacing, repeated after disopryamide, resulted in the conversion of atrial flutter to sinus rhythm. In this study, overdrive atrial pacing and intravenous disopyramide, singly and in combination, terminated atrial flutter in nine of the 10 patients and it is suggested that this method may provide an effective alternative to direct current cardioversion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426181      PMCID: PMC482392          DOI: 10.1136/hrt.44.3.240

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  40 in total

1.  Utility and limitations of intravenous quinidine in arrhythmias.

Authors:  L J ACIERNO; R GUBNER
Journal:  Am Heart J       Date:  1951-05       Impact factor: 4.749

2.  Rapid atrial stimulation: successful method of conversion of atrial flutter and atrial tachycardia.

Authors:  D E Pittman; J S Makar; K S Kooros; C R Joyner
Journal:  Am J Cardiol       Date:  1973-10       Impact factor: 2.778

3.  Rapid atrial pacing in conversion of atrial flutter.

Authors:  T O Cheng
Journal:  Am J Cardiol       Date:  1973-02       Impact factor: 2.778

4.  Right atrial stimulation in the treatment of atrial flutter.

Authors:  H J Zeft; F R Cobb; M B Waxman; N C Hunt; J J Morris
Journal:  Ann Intern Med       Date:  1969-03       Impact factor: 25.391

5.  Conversion of supraventricular tachycardias with atrial stimulation. Evidence for re-entry mechanisms.

Authors:  N C Hunt; F R Cobb; M B Waxman; H J Zeft; R H Peter; J J Morris
Journal:  Circulation       Date:  1968-12       Impact factor: 29.690

6.  [Treatment of auricular flutter using endocavitary auricular stimulation].

Authors:  P Puech; R Grolleau; H Latour; J Cabasson; J M Robin; C Baissus
Journal:  Arch Mal Coeur Vaiss       Date:  1973-02

Review 7.  Refractoriness of cardiac tissue.

Authors:  W Gough; L S Dreifus; I M de Azevedo; M R Katz
Journal:  Cardiovasc Clin       Date:  1974

8.  The mechanism of flutter and fibrillation.

Authors:  D Scherf
Journal:  Am Heart J       Date:  1966-02       Impact factor: 4.749

9.  The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome.

Authors:  D Durrer; L Schoo; R M Schuilenburg; H J Wellens
Journal:  Circulation       Date:  1967-11       Impact factor: 29.690

10.  Termination of atrial flutter and atrial tachycardia with rapid atrial stimulation.

Authors:  D E Pittman; T C Gay; I I Patel; C R Joyner
Journal:  Angiology       Date:  1975-12       Impact factor: 3.619

View more
  2 in total

1.  Successful intracardiac electrical conversion of atrial flutter in patients with complex congenital heart disease.

Authors:  D Cunningham; J Somerville; J A Kennedy; E Rowland; A F Rickards
Journal:  Br Heart J       Date:  1991-06

Review 2.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.